Drawing for JYMED PEPTIDE

USPTO serial 86823250

JYMED PEPTIDE

Reviewed by CopyMark Law Group

Reg. 5715808Status 704Registered
Filing date
Status date
Registration date
Apr 2, 2019
Examiner
GARCIA, CLAUDIA
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 704 applies to Madrid Protocol extensions of protection in the U.S. Section 71 (similar to Section 8) showing continued use was accepted. The U.S. extension remains active. Follow Madrid and USPTO deadlines for the next renewal cycle.

Status 704: Status 704 applies to Madrid Protocol extensions of protection in the U.S. Section 71 (similar to Section 8) showing continued use was accepted. The U.S. extension remains active.

Need help with JYMED PEPTIDE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Timothy T. Wang

Timothy T. Wang NI WANG & MASSAND PLLC8140 WALNUT HILL LN STE 615DALLAS, TX 75231United States

Goods and services

ClassDescriptionStatusFirst use
005Medicines for human purposes for the treatment of tumor or cancer, inflammation, diabetes, osteoporosis, immune diseases, dermal diseases, cardiovascular diseases, central nervous system diseases, respiratory diseases and disorders, gastrointestinal diseases, bacterial or fungal infection containing peptides; Pharmaceutical preparations for the treatment of tumor or cancer, inflammation, diabetes, osteoporosis, immune diseases, dermal diseases, cardiovascular diseases, central nervous system diseases, respiratory diseases and disorders, gastrointestinal diseases, bacterial or fungal infection containing peptides; Drugs for medical purposes, namely, drugs for the treatment of tumor or cancer, inflammation, diabetes, osteoporosis, immune diseases, dermal diseases, cardiovascular diseases, central nervous system diseases, respiratory diseases and disorders, gastrointestinal diseases, bacterial or fungal infection containing peptides; Active synthetic peptides used for the prevention and treatment of tumor or cancer, inflammation, diabetes, osteoporosis, immune diseases, dermal diseases, cardiovascular diseases, central nervous system diseases, respiratory diseases and disorders, gastrointestinal diseases, bacterial or fungal infection; Nutritional supplements containing peptides; Veterinary preparations, namely, pain relief medication containing peptides; Veterinary preparations for treatment of intestinal bacteria, parasite, infectious diseases, digestive system disease, respiratory disease, reproductive diseases containing peptides; Biological preparations for veterinary purposes, namely, for domestic animals and livestock for the prevention and treatment of infectious diseases, bacterial infections, hypertension, cardiovascular disease, urinary infections, renal disease, reproductive diseases containing peptides; Dietary supplements for animals containing peptidesACTIVEJul 21, 2016
035[ Advertising; Medical supplies retail store and wholesale distributorship services; Business management and organization consulting; Providing an online market of goods and services for buyers and sellers; Sales promotion for others; Import-export agencies; Retail store and wholesale distributorship services for pharmaceutical, veterinary and sanitary preparations and medical supplies; Systemization of information into computer databases; Drug retail store and wholesale distributorship services; Veterinary drug retail store and wholesale distributorship services ]SECTION 8 - CANCELLEDMay 9, 2016

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 26, 2025NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
Apr 26, 20258.PRREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED—
Apr 26, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 7, 2024ES8RTEAS SECTION 8 RECEIVED—
Apr 2, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Apr 2, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 27, 2019SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Feb 26, 2019CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Feb 15, 2019SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Feb 14, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 24, 2019IUAFUSE AMENDMENT FILED—
Jan 24, 2019EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Dec 25, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 13, 2018TMBNTTAB RELEASE CASE TO TRADEMARKS—
Nov 13, 2018OP.TOPPOSITION TERMINATED NO. 999999—
Nov 13, 2018OP.DOPPOSITION DISMISSED NO. 999999—
Apr 30, 2018CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 30, 2018COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 27, 2018OP.IOPPOSITION INSTITUTED NO. 999999—
Nov 22, 2017ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Oct 31, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 31, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 11, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 26, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 25, 2017ALIEASSIGNED TO LIE—
Sep 12, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 6, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Sep 6, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 6, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 6, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 11, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 8, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 8, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 23, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 23, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 23, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 3, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 1, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 1, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 27, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 27, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 27, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 17, 2017ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Feb 7, 2017PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Jan 24, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 23, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Jan 23, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 23, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 23, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 1, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 30, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 30, 2016ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Oct 12, 2016GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Oct 12, 2016GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 12, 2016CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 14, 2016DOCKASSIGNED TO EXAMINER—
Sep 1, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 31, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 31, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 14, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 14, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 14, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 9, 2016DOCKASSIGNED TO EXAMINER—
Nov 21, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 20, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance